Highlander Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$514K |
| 2 |
Pfizer
PFE
|
+$474K |
| 3 |
Chevron
CVX
|
+$342K |
| 4 |
Home Depot
HD
|
+$315K |
| 5 |
Sprott Physical Silver Trust
PSLV
|
+$284K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$577K |
| 2 |
United Airlines
UAL
|
+$443K |
| 3 |
NVIDIA
NVDA
|
+$388K |
| 4 |
UMH
UMH Properties
UMH
|
+$362K |
| 5 |
Chemours
CC
|
+$329K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.9% |
| 2 | Technology | 12.71% |
| 3 | Financials | 12.03% |
| 4 | Consumer Discretionary | 8.42% |
| 5 | Communication Services | 7.88% |
Similar funds
Highlander Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Highlander Capital Management held 660 positions worth $159M, up 14% from $139M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Highlander Capital Management withdrew a net $22M in Q2 2020, closing 65 positions and reducing 55 holdings. Its most notable exit was Humana, an estimated $314K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Financials.
Against the trend, Highlander Capital Management opened a new position in Invesco Pharmaceuticals ETF worth $52K.
- Highlander Capital Management's largest Q2 2020 buy was Invesco Pharmaceuticals ETF: 800 shares worth $52K.
- Highlander Capital Management added most to AT&T in Q2 2020, an estimated $514K increase.
- Highlander Capital Management's biggest Q2 2020 reduction was CVS Health, cutting an estimated $577K.
- Highlander Capital Management fully exited Humana in Q2 2020, selling an estimated $314K.
- Highlander Capital Management's ten largest holdings make up 30% of its $159M portfolio in Q2 2020.
- Highlander Capital Management opened 12 new positions and closed 65 in Q2 2020.
- Highlander Capital Management's portfolio value rose 14% quarter-over-quarter to $159M.
Based on Highlander Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.